Suppr超能文献

Response: Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study.

作者信息

Pira Anna, Moltrasio Chiara, Abeni Damiano, Corrà Alberto, Marzano Angelo Valerio, Caproni Marzia, Di Zenzo Giovanni

机构信息

Molecular and Cell Biology Laboratory, Istituto Dermopatico dell'immacolata (IDI)-IRCCS, Rome, Italy.

Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

出版信息

Front Med (Lausanne). 2023 Mar 16;10:1160672. doi: 10.3389/fmed.2023.1160672. eCollection 2023.

Abstract
摘要

相似文献

1
Response: Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study.
Front Med (Lausanne). 2023 Mar 16;10:1160672. doi: 10.3389/fmed.2023.1160672. eCollection 2023.
2
Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study.
Front Med (Lausanne). 2022 Dec 19;9:1096867. doi: 10.3389/fmed.2022.1096867. eCollection 2022.
3
A case of acquired hemophilia A and bullous pemphigoid following SARS-CoV-2 mRNA vaccination.
J Formos Med Assoc. 2022 Sep;121(9):1872-1876. doi: 10.1016/j.jfma.2022.02.017. Epub 2022 Mar 14.
5
Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine.
Ann Dermatol Venereol. 2022 Mar;149(1):56-57. doi: 10.1016/j.annder.2021.07.008. Epub 2021 Sep 30.
6
COVID-19 and autoimmune bullous diseases: Lessons learned.
Autoimmun Rev. 2023 Apr;22(4):103286. doi: 10.1016/j.autrev.2023.103286. Epub 2023 Feb 2.
7
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study.
J Eur Acad Dermatol Venereol. 2022 Dec;36(12):2473-2481. doi: 10.1111/jdv.18441. Epub 2022 Sep 10.
8
A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccine.
J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e13-e16. doi: 10.1111/jdv.17676. Epub 2021 Oct 5.
9
Bullous pemphigoid and COVID-19 vaccine.
Med Clin (Barc). 2021 Nov 26;157(10):e333-e334. doi: 10.1016/j.medcli.2021.05.005. Epub 2021 May 27.
10
Bullous pemphigoid triggered by COVID-19 vaccine: Rapid resolution with corticosteroid therapy.
Dermatol Ther. 2022 Jan;35(1):e15208. doi: 10.1111/dth.15208. Epub 2021 Nov 30.

引用本文的文献

1
COVID-19 Vaccine: A Potential Risk Factor for Accelerating the Onset of Bullous Pemphigoid.
Vaccines (Basel). 2024 Sep 5;12(9):1016. doi: 10.3390/vaccines12091016.
2
The mRNA-LNP vaccines - the good, the bad and the ugly?
Front Immunol. 2024 Feb 8;15:1336906. doi: 10.3389/fimmu.2024.1336906. eCollection 2024.

本文引用的文献

1
Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine.
Front Med (Lausanne). 2023 Jan 19;10:1112823. doi: 10.3389/fmed.2023.1112823. eCollection 2023.
2
Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study.
Front Med (Lausanne). 2022 Dec 19;9:1096867. doi: 10.3389/fmed.2022.1096867. eCollection 2022.
3
Association between COVID-19 vaccination and autoimmune bullous diseases: a random coincidence or rare event.
J Eur Acad Dermatol Venereol. 2022 Sep;36(9):e665-e666. doi: 10.1111/jdv.18202. Epub 2022 May 18.
5
Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study.
Front Med (Lausanne). 2022 Feb 28;9:841506. doi: 10.3389/fmed.2022.841506. eCollection 2022.
6
Evaluating risk of bullous pemphigoid after mRNA COVID-19 vaccination.
Br J Dermatol. 2022 Aug;187(2):271-273. doi: 10.1111/bjd.21240. Epub 2022 May 24.
7
Absolving COVID-19 Vaccination of Autoimmune Bullous Disease Onset.
Front Immunol. 2022 Feb 18;13:834316. doi: 10.3389/fimmu.2022.834316. eCollection 2022.
8
Case Report: Circulating Anti-SARS-CoV-2 Antibodies Do Not Cross-React With Pemphigus or Pemphigoid Autoantigens.
Front Med (Lausanne). 2021 Dec 20;8:807711. doi: 10.3389/fmed.2021.807711. eCollection 2021.
9
New-onset autoimmune phenomena post-COVID-19 vaccination.
Immunology. 2022 Apr;165(4):386-401. doi: 10.1111/imm.13443. Epub 2022 Jan 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验